Updated Jul 16, 2026
Krebs Andreas has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the SEC filing context dated 2026-06-15, Krebs Andreas is an insider associated with Definium Therapeutics, Inc. in the biopharmaceutical sector. The available public data does not clearly disclose his exact title (e.g., director, officer, or other insider) or provide a detailed biographical history. He appears in SEC disclosures related to Definium Therapeutics, suggesting involvement as a company insider or beneficial holder. There is no widely published biographical profile or verified net worth information readily available from public sources in the context of these filings. The entry is derived from regulatory disclosures and should be corroborated with official company leadership pages or additional regulatory filings for precise identification.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | DFTX | Definium Therapeutics, Inc. | A — Grant or award | 4.7K | $0.00 |
Based on the SEC filing context dated 2026-06-15, Krebs Andreas is an insider associated with Definium Therapeutics, Inc. in the biopharmaceutical sector. The available public data does not clearly disclose his exact title (e.g., director, officer, or other insider) or provide a detailed biographical history. He appears in SEC disclosures related to Definium Therapeutics, sugge…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Krebs Andreas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.